<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144153</url>
  </required_header>
  <id_info>
    <org_study_id>19-0728</org_study_id>
    <nct_id>NCT04144153</nct_id>
  </id_info>
  <brief_title>Opioid Free Anesthesia and Bariatric Surgery</brief_title>
  <official_title>Opioid Free Total Intravenous Anesthesia Within an Enhanced Recovery After Surgery Pathway for Bariatric Surgery: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The morbidly obese bariatric surgery population is susceptible to opioid-induced
      complications such as respiratory depression and postoperative nausea and vomiting. This
      population may in particular benefit from opioid-sparing or opioid-free anesthetic
      techniques. This study aims to evaluate the effect of opioid free total intravenous
      anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery</measure>
    <time_frame>Up to two postoperative weeks</time_frame>
    <description>Quality of Recovery (QoR-15), a patient-reported outcome questionnaire that assesses the quality of functional recovery after surgery and anesthesia with a minimum score of 0 (very poor recovery) and a maximum score of 150 (excellent recovery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Intensities</measure>
    <time_frame>Up to postoperative day one</time_frame>
    <description>Postoperative pain intensities using a 0 to 10 numerical rating scale (NRS) with higher scores indicative of higher pain intensities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>Up to postoperative day one</time_frame>
    <description>Total postoperative opioid consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Aldrete Score of 9</measure>
    <time_frame>Up to postoperative day one</time_frame>
    <description>Time to post-anesthesia care unit discharge readiness</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative Nausea and Vomiting</measure>
    <time_frame>Up to postoperative day one</time_frame>
    <description>The incidence of any postoperative nausea, retching, or vomiting.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Postoperative Quality of Recovery</condition>
  <arm_group>
    <arm_group_label>Opioid Free Anesthesia Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid Anesthesia Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Opioid Free Total Intravenous Anesthesia</intervention_name>
    <description>Total intravenous anesthesia with propofol and dexmedetomidine hydrochloride and ketamine hydrochloride</description>
    <arm_group_label>Opioid Free Anesthesia Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Total Intravenous anesthesia with opioid</intervention_name>
    <description>Total Intravenous anesthesia with opioid</description>
    <arm_group_label>Opioid Anesthesia Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  Non-pregnant

          -  Undergoing laparoscopic bariatric surgery for weight loss.

        Exclusion Criteria:

          -  Unable to obtain informed consent or consent withdrawn.

          -  Patients who are pregnant or nursing.

          -  ASA IV-V

          -  Alcohol or narcotic misuse or dependence in the last 2 years.

          -  Preoperative daily opioid use for one year for pain management.

          -  Egg or soy product allergy

          -  Active liver disease

          -  Patients with left ventricular assist devices

          -  Abnormal renal function

          -  Any contraindication to any opioid or non-opioid pain analgesics

          -  Any physical, mental or medical condition that in the opinion of the investigator,
             makes study participation inadvisable.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judith Aronsohn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwell Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judith Aronsohn, MD</last_name>
    <phone>718-470-5382</phone>
    <email>jaronsohn@northwell.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Oonagh Dowling, PhD</last_name>
    <phone>718-470-7630</phone>
    <email>odowling@northwell.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 28, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

